Annals of hepatology (615 documentos)


1.- A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2
Waisbourd-Zinman, Orith1; Surrey, Lea F1; Schwartz, Anna E1; Russo, Pierre A1; Wen, Jessica1
1Children's Hospital of Philadelphia, Division of Gastroenterology, Hepatology and Nutrition, Filadelfia, Pensilvania. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 465-468]
2.- Cholangiohydatidosis: an Infrequent Cause of Obstructive Jaundice and Acute Cholangitis
Manterola, Carlos1; Otzen, Tamara2
1Universidad de La Frontera, Centro de Estudios Morfológicos y Quirúrgicos, Temuco, Cautín. Chile; 2Universidad Autónoma de Chile, Centro de Investigación Biomédica, Temuco, Cautín. Chile
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 436-441]
3.- Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B
Oyagüez, Itziar1; Buti, María2; Brosa, Max3; Rueda, Magdalena4; Casado, Miguel A1
1Pharmacoeconomics & Outcomes Research Iberia, Pozuelo de Alarcón, Madrid. España; 2Hospital Vall d'Hebron, Barcelona. España; 3Oblikue Consulting, Barcelona. España; 4Gilead Sciences, Madrid. España
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 358-365]
4.- Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy
Langness, Jacob A1; Tabano, David2; Wieland, Amanda3; Tise, Sarah3; Pratt, Lindsay3; Ayres Harrington, Lauren1; Lin, Sonia1; Ghuschcyan, Vahram2; Nair, Kavita V2; Everson, Gregory T3
1University Of Colorado Hospital, Department of Pharmacy, Aurora, Colorado. Estados Unidos de América; 2University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado. Estados Unidos de América; 3University of Colorado Denver, School of Medicine, Denver, Colorado. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 366-374]
5.- Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality
Rathi, Chetan1; Pipaliya, Nirav1; Patel, Ruchir1; Ingle, Meghraj1; Phadke, Aniruddha1; Sawant, Prabha1
1Lokmanya Tilak Municipal Medical College, Department of Gastroenterology, Bombay, Maharashtra. India
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 442-450]
6.- GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors
Greni, Federico1; Valenti, Luca2; Mariani, Raffaella3; Pelloni, Irene3; Rametta, Raffaela2; Busti, Fabiana4; Piperno, Alberto1; Ravasi, Giulia1; Girelli, Domenico4; Fargion, Silvia2; Galimberti, Stefania1; Pelucchi, Sara1
1Universita di Milano-Bicocca, Scuola di Medicina e Chirurgia, Monza, Lombardía. Italia; 2Universita di Milano, Ospedale Maggiore Policlinico, Milán, Lombardia. Italia; 3Azienda Socio Sanitaria Territoriale di Monza, Ospedale San Gerardo, Monza, Lombardía. Italia; 4Universita di Verona, Policlinico GB Rossi, Verona, Veneto. Italia
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 451-456]
7.- HbA1c Levels as a Parameter of Glycemic Control in Patients with Liver Diseases
Schiavon, Leonardo de Lucca1; Narciso-Schiavon, Janaina Luz1
1Universidade Federal de Santa Catarina, Hospital Universitario, Florianopolis, Santa Catarina. Brasil
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 469-470]
8.- Liver Transplantation as Cure of Hepatocellular Carcinoma: It is not a Matter of Time, it is a Matter of Tumor Biology
Jochum, Christoph1; Canbay, Ali2
1University Duisburg-Essen, University Hospital, Essen, Nordrhein-Westfalen. Alemania; 2Otto von Guericke University, Department of Gastroenterology, Hepatology and Infectious Diseases, Magdeburgo, Sajonia-Anhalt. Alemania
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 326-327]
9.- Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center
Palmer, William C1; Lee, David1; Burns, Justin1; Croome, Kristopher1; Rosser, Barry1; Patel, Tushar1; Keaveny, Andrew P1; Pungpapong, Surakit1; Satyanarayana, Raj; Yataco, Maria1; Nakhleh, Raouf2; Musto, Kaitlyn R1; Canabal, Alexandra M3; Turnage, Alex K3; Hodge, David O4; Nguyen, Justin H1; Harnois, Denise M1
1Mayo Clinic, Department of Transplant, Jacksonville, Florida. Estados Unidos de América; 2Mayo Clinic, Department of Pathology, Jacksonville, Florida. Estados Unidos de América; 3Mayo Clinic, CRISP Program, Jacksonville, Florida. Estados Unidos de América; 4Mayo Clinic, Department of Health Sciences Research, Jacksonville, Florida. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 402-411]
10.- MRE in NAFLD: Promising but Further Validation is Required
Ryan, John D1; Tsochatzis, Emmanuel A1
1Royal Free Hospital, Sheila Sherlock Liver Unit, Londres. Reino Unido
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 331-332]
11.- Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant
Yoshida, Eric M1; Kwo, Paul2; Agarwal, Kosh3; Duvoux, Christophe4; Durand, Francois5; Peck Radosavljevic, Markus6; Lilly, Leslie7; Willems, Bernard8; Vargas, Hugo9; Kumar, Princy10; Brown-Junior, Robert S11; Horsmans, Yves12; De Oertel, Shampa13; Arterburn, Sarah13; Dvory Sobol, Hadas13; Brainard, Diana M13; McHutchison, John G13; Terrault, Norah14; Rizzetto, Mario15; Mullhaupt, Beat16
1Vancouver General Hospital, Division of Gastroenterology, Vancouver, Columbia Británica. Canadá; 2Indiana University, School of Medicine, Indianapolis, Indiana. Estados Unidos de América; 3King’s College Hospital Foundation Trust, Institute of Liver Studies, Londres. Reino Unido; 4Universite Paris-Est Creteil, Centre Hospitalier Universitaire Henri-Mondor, Val de Marne, París. Francia; 5Universite Paris Diderot, Beaujon Hospital, Clichy, París. Francia; 6Medical University of Vienna, Department of Gastroenterology and Hepatology, Viena. Austria; 7University of Toronto, Toronto General Hospital, Toronto, Ontario. Canadá; 8Universite de Montreal, Hospital Saint Luc, Montreal, Quebec. Canadá; 9Mayo Clinic, Division of Gastroenterology and Hepatology, Phoenix, Arizona. Estados Unidos de América; 10Georgetown University, Division of Infectious Diseases, Washington, Distrito de Columbia. Estados Unidos de América; 11Weill Cornell Medical College, Division of Gastroenterology and Hepatology, Nueva York. Estados Unidos de América; 12Universite Catholique de Louvain, Lovaina. Bélgica; 13Gilead Sciences, Inc., Foster City, California. Estados Unidos de América; 14University of California, Division of Gastroenterology and Hepatology, San Francisco, California. Estados Unidos de América; 15Universita di Torino, Dipartimento di Gastroenterologia, Turín, Piemonte. Italia; 16University Hospital Zurich, Department for Gastroenterology and Hepatology, Zurich. Suiza
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 375-381]
12.- Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
Vinaixa, Carmen1; Berenguer, Marina1
1Hospital Universitari i Politecnic La Fe, Departamento de Gastroenterología, Valencia. España
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 322-323]
13.- Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A Report of Excellence
Teschke, Rolf1; Danan, Gaby
1Goethe University, Medical Faculty, Frankfurt, Hessen. Alemania
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 324-325]
14.- Recurrent Hyperammonemia After Abernethy Malformation Type 2 Closure: a Case Report
Li, Hui1; Ma, Zhi1; Xie, Ying1; Tian, Feng1
1China Medical University, Shengjing Hospital, Shenyang, Liaoning. China
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 460-464]
15.- Reply to “HbA1c Levels as a Parameter of Glycemic Control in Patients with Liver Cirrhosis”
Stine, Jonathan G1; Wynter, Javelle A1; Niccum, Blake1; Kelly, Virginia1; Caldwell, Stephen H1; Shah, Neeral L1; Narciso-Schiavon, Janaina Luz1
1University of Virginia, School of Medicine, Charlottesville, Virginia. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 471-472]
16.- Risk Factors for Prognosis of Hepatocellular Carcinoma After Curative Resection In Patients with Low Hepatitis B Viral Load
Qu, Li-Shuai1; Liu, Jin-Xia1; Zhu, Jing1; Lu, Cui-Hua1
1Affiliated Hospital of Nantong University, Department of Gastroenterology, Jiangsu Nantong. China
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 412-420]
17.- Spontaneous Resolution of Multiple Hepatic Masses: Hepatic Inflammatory Pseuduotumor
Qi, Xingshun1; Han, Lei2; Arora, Ankur3; Hou, Yue1; Wang, Ran1; Chang, Sha1; Guo, Xiaozhong1
1General Hospital of Shenyang, Department of Gastroenterology, Shenyang, Liaoning. China; 2General Hospital of Shenyang, Department of Hepatobiliary Surgery, Shenyang, Liaoning. China; 3Worthing Hospital, Department of Radiology, Worthing, West Sussex. Reino Unido
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 457-459]
18.- Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis
Chaiteerakij, Roongruedee1; Chattieng, Piyanat1; Choi, Jonggi2; Pinchareon, Nutcha1; Thanapirom, Kessirin1; Geratikornsupuk, Nopavut1
1Thai Red Cross Society, King Chulalongkorn Memorial Hospital, Bangkok, Phra Nakhon. Tailandia; 2Presence Saint Francis Hospital, Department of Internal Medicine, Evanston, Illinois. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 421-429]
19.- Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Jaruvongvanich, Veeravich1; Sanguankeo, Anawin2; Riangwiwat, Tanawan1; Upala, Sikarin2
1University of Hawaii, Department of Internal Medicine, Honolulu, Hawaii. Estados Unidos de América; 2Bassett Medical Center, Department of Internal Medicine, Cooperstown, New York. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 382-394]
20.- The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
Chinchilla López, Paulina1; Qi, Xingshun2; Yoshida, Eric M3; Méndez Sánchez, Nahum1
1Fundación Clínica Médica Sur, Unidad de Investigación de Hígado, Ciudad de México. México; 2General Hospital of Shenyang Military Area, Department of Gastroenterology, Shenyang, Liaoning. China; 3Vancouver General Hospital, Division of Gastroenterology, Vancouver, Columbia Británica. Canadá
[Annals of hepatology, México, 2017 Vol. 16 Num. 3 May-Jun, Pag. 328-330]